Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07UPJ
|
||||
Former ID |
DIB014003
|
||||
Drug Name |
NMDA NR2B antagonists
|
||||
Synonyms |
NMDA NR2B antagonists (depression); NMDA NR2B antagonists (depression), AstraZeneca
|
||||
Indication | Major depressive disorder [ICD9: 296.2, 296.3, 710.0; ICD10:F32, F33, M32] | Investigative | [552160] | ||
Company |
AstraZeneca plc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1c(ccc(c1OC)c1cc(cnc1)CNC1CCCC1)F
|
||||
Target and Pathway | |||||
Target(s) | Glutamate [NMDA] receptor subunit epsilon 2 | Target Info | Antagonist | [543838] | |
KEGG Pathway | Ras signaling pathway | ||||
Rap1 signaling pathway | |||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Circadian entrainment | |||||
Long-term potentiation | |||||
Glutamatergic synapse | |||||
Dopaminergic synapse | |||||
Alzheimer's disease | |||||
Amyotrophic lateral sclerosis (ALS) | |||||
Huntington's disease | |||||
Cocaine addiction | |||||
Amphetamine addiction | |||||
Nicotine addiction | |||||
Alcoholism | |||||
Systemic lupus erythematosus | |||||
Pathway Interaction Database | ErbB4 signaling events | ||||
Reelin signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.